These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 7812482)
21. It is wise to prescribe NSAIDs with modern gastroprotective agents? Cucala M; Bauerfeind P; Emde C; Gonvers JJ; Koelz HR; Blum AL Scand J Rheumatol Suppl; 1987; 65():141-54. PubMed ID: 3317804 [TBL] [Abstract][Full Text] [Related]
22. Peptic ulcer disease in the elderly. Gilinsky NH Gastroenterol Clin North Am; 1990 Jun; 19(2):255-71. PubMed ID: 2194945 [TBL] [Abstract][Full Text] [Related]
23. Association of adrenocorticosteroid therapy and peptic-ulcer disease. Messer J; Reitman D; Sacks HS; Smith H; Chalmers TC N Engl J Med; 1983 Jul; 309(1):21-4. PubMed ID: 6343871 [TBL] [Abstract][Full Text] [Related]
24. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
25. [Drug-induced hemorrhages of the gastrointestinal tract]. Berndt H Z Arztl Fortbild (Jena); 1983; 77(12):503-6. PubMed ID: 6603719 [No Abstract] [Full Text] [Related]
26. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Savage RL; Moller PW; Ballantyne CL; Wells JE Arthritis Rheum; 1993 Jan; 36(1):84-90. PubMed ID: 8424842 [TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. An overview. Silverstein F Postgrad Med; 1991 May; 89(7):33-40. PubMed ID: 2031029 [TBL] [Abstract][Full Text] [Related]
28. Number needed to kill. Individual drug risk with NSAIDs. Bolten WW Z Rheumatol; 2001 Aug; 60(4):288. PubMed ID: 11584724 [No Abstract] [Full Text] [Related]
29. [Nonsteroidal anti-inflammatory agents--choice between disturbances of gastrointestinal tract and cardiovascular toxicity]. Gumbrevicius G; Milasius A; Sveikata A Medicina (Kaunas); 2006; 42(5):429-39. PubMed ID: 16778472 [TBL] [Abstract][Full Text] [Related]
31. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Armstrong CP; Blower AL Gut; 1987 May; 28(5):527-32. PubMed ID: 3596334 [TBL] [Abstract][Full Text] [Related]
32. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403 [TBL] [Abstract][Full Text] [Related]